| Primary |
| Psoriasis |
69.6% |
| Product Used For Unknown Indication |
21.7% |
| Anxiety |
4.3% |
| Hypertension |
4.3% |
|
| Biliary Cirrhosis Primary |
9.1% |
| Blood Phosphorus Decreased |
9.1% |
| Cellulitis |
9.1% |
| Drug Screen Positive |
9.1% |
| Osteoporosis |
9.1% |
| Photosensitivity Reaction |
9.1% |
| Post Lumbar Puncture Syndrome |
9.1% |
| Rash |
9.1% |
| Thrombocytopenia |
9.1% |
| Toxicity To Various Agents |
9.1% |
| Vitamin B12 Decreased |
9.1% |
|
| Secondary |
| Psoriasis |
50.0% |
| Psoriatic Arthropathy |
16.7% |
| Rheumatoid Arthritis |
11.1% |
| Cellulitis |
5.6% |
| Drug Eruption |
5.6% |
| Hyperlipidaemia |
5.6% |
| Hypertension |
5.6% |
|
| Large Intestine Polyp |
25.0% |
| Mydriasis |
25.0% |
| Rash |
25.0% |
| Transaminases Increased |
25.0% |
|
| Concomitant |
| Psoriasis |
34.6% |
| Product Used For Unknown Indication |
18.8% |
| Drug Use For Unknown Indication |
10.5% |
| Psoriatic Arthropathy |
6.5% |
| Hypertension |
4.8% |
| Ankylosing Spondylitis |
3.9% |
| Diabetes Mellitus |
3.0% |
| Pain |
2.6% |
| Back Pain |
2.3% |
| Diabetic Neuropathy |
1.5% |
| Anxiety |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Blood Cholesterol |
1.3% |
| Depression |
1.3% |
| Blood Cholesterol Increased |
1.1% |
| Insomnia |
1.1% |
| Hypersensitivity |
1.0% |
| Hypothyroidism |
1.0% |
| Muscle Spasms |
1.0% |
| Atrial Fibrillation |
0.9% |
|
| Psoriasis |
13.6% |
| Drug Ineffective |
6.2% |
| Death |
4.9% |
| Injection Site Pain |
4.9% |
| Myocardial Infarction |
4.9% |
| Paraesthesia |
4.9% |
| Pruritus |
4.9% |
| Pyrexia |
4.9% |
| Rash |
4.9% |
| Rash Pruritic |
4.9% |
| Renal Failure |
4.9% |
| Weight Increased |
4.9% |
| Wheezing |
4.9% |
| Abortion Spontaneous |
3.7% |
| Cardiac Failure Congestive |
3.7% |
| Pulmonary Embolism |
3.7% |
| Sinusitis |
3.7% |
| Skin Exfoliation |
3.7% |
| Type 1 Diabetes Mellitus |
3.7% |
| Urinary Tract Infection |
3.7% |
|
